Scarica l'app Stockscreener
57.86
1.67%
-0.98
Dopo l'orario di chiusura:
57.96
0.10
+0.17%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$58.84
Aprire:
$58.82
Volume 24 ore:
2.05M
Relative Volume:
0.76
Capitalizzazione di mercato:
$13.13B
Reddito:
$4.03B
Utile/perdita netta:
$789.50M
Rapporto P/E:
17.38
EPS:
3.33
Flusso di cassa netto:
$1.15B
1 W Prestazione:
-1.03%
1M Prestazione:
-4.69%
6M Prestazione:
-29.15%
1 anno Prestazione:
-25.38%
Intervallo 1D:
$57.64
$58.88
Intervallo di 1 settimana:
$56.27
$60.88
Portata 52W:
$56.27
$84.67
Hologic Inc Stock (HOLX) Company Profile
Nome
Hologic Inc
Settore
Industria
Telefono
(508) 263-2900
Indirizzo
250 CAMPUS DRIVE, MARLBOROUGH, MA
Confronta HOLX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
57.86 | 13.13B | 4.03B | 789.50M | 1.15B | 3.33 |
|
ISRG
Intuitive Surgical Inc
|
488.27 | 174.93B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
202.04 | 58.01B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
91.42 | 45.22B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
213.97 | 31.43B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
77.80 | 15.49B | 3.90B | 392.30M | 288.10M | 1.95 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-03 | Downgrade | Argus | Buy → Hold |
| 2025-02-06 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Downgrade | Needham | Buy → Hold |
| 2024-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2024-12-10 | Iniziato | Jefferies | Hold |
| 2024-12-10 | Reiterato | Needham | Buy |
| 2024-10-01 | Downgrade | Citigroup | Buy → Neutral |
| 2024-06-27 | Iniziato | Stephens | Overweight |
| 2024-04-03 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-07-14 | Aggiornamento | Needham | Hold → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-07-20 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-07-20 | Iniziato | UBS | Neutral |
| 2022-07-18 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Downgrade | Citigroup | Buy → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-10-14 | Iniziato | Redburn | Neutral |
| 2021-07-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Downgrade | Needham | Buy → Hold |
| 2020-11-05 | Reiterato | Needham | Buy |
| 2020-06-30 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2020-06-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Reiterato | Needham | Buy |
| 2020-04-30 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Reiterato | Needham | Buy |
| 2019-05-02 | Reiterato | Needham | Buy |
| 2019-01-31 | Reiterato | Needham | Buy |
| 2019-01-02 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Iniziato | UBS | Neutral |
| 2018-09-13 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Hologic Inc Borsa (HOLX) Ultime notizie
Sentinel Node Biopsy Market to Witness Remarkable Growth with - openPR.com
BofA Reduces Price Target for Hologic (HOLX) Amid Industry Headw - GuruFocus
Why Hologic (HOLX) Outpaced the Stock Market Today - Nasdaq
What Does Hologic, Inc.'s (NASDAQ:HOLX) Share Price Indicate? - Yahoo Finance
Fluoroscopy Devices Market Is Booming Worldwide with Positive - openPR.com
Breast Cancer Brachytherapy Market Future Business - openPR.com
Immunoassay Analyzers Market Size to Hit USD 10.16 Billion by 2032 | SNS Insider - GlobeNewswire Inc.
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know - MSN
X-ray Machine Manufacturing Market Generated Opportunities, - openPR.com
Hologic stock hits 52-week low at $57.36 amid market shifts - Investing.com India
Hologic stock hits 52-week low at $57.36 amid market shifts By Investing.com - Investing.com South Africa
Non-Invasive Cancer Diagnostics Market to Witness Massive - openPR.com
Q4 Earnings Outperformers: Hologic (NASDAQ:HOLX) And The Rest Of The Medical Devices & SuppliesImaging, Diagnostics Stocks - Yahoo Finance
Analyzing Hologic, Inc. v. Stepp: Key takeaways - Eversheds Sutherland
Histology And Cytology Market Is Booming Worldwide 2025-2032 | - openPR.com
Digital X-ray Devices Market to Witness Massive Growth by 2032 | - openPR.com
Virology Testing Market to Witness Remarkable Growth with - openPR.com
RBC Cuts Price Target on Hologic to $75 From $83, Keeps Sector Perform Rating - MarketScreener
Hologic (HOLX) Advances While Market Declines: Some Information for Investors - Yahoo Finance
Hologic adds Solventum CFO McMillan to its board - MassDevice
Hologic Brings In New Leadership: A Signal To Stay Put With The Stock? - Barchart.com
Hologic Brings in New Leadership: A Signal to Stay Put With the Stock? - Yahoo Finance
Hologic Onboards Wayde McMillan to its Board of Directors - World Business Outlook
Wayde McMillan Elected to Hologic Board of Directors - citybiz
Hologic adds Wayde McMillan to its Board of Directors By Investing.com - Investing.com South Africa
Hologic Expands Board with New Director Appointment - TipRanks
Hologic adds Wayde McMillan to its Board of Directors - Investing.com
Wayde Mcmillan Elected To Hologic Board Of Directors - MarketScreener
Wayde McMillan Elected to Hologic Board of Directors – Company Announcement - Financial Times
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025 - MarketScreener
Biopsy Devices Market Projected To Witness Massive Growth, - openPR.com
Groupama Asset Managment Acquires 21,037 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Mark Your Calendar: Hologic Sets Critical Q2 Earnings Report Date - Stock Titan
Evercore ISI Adjusts Price Target on Hologic to $65 From $73, Maintains In Line Rating - MarketScreener
Mitsubishi UFJ Trust & Banking Corp Has $13.99 Million Stock Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
RBC Adjusts Price Target on Hologic to $83 From $85, Maintains Sector Perform Rating - MarketScreener
Bone Densitometers Market Future Business Opportunities - openPR.com
Hologic (HOLX) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Declining Stock and Decent Financials: Is The Market Wrong About Hologic, Inc. (NASDAQ:HOLX)? - simplywall.st
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Hologic, Inc. (NASDAQ:HOLX) Shares Sold by Prudential Financial Inc. - MarketBeat
Hologic Inc Azioni (HOLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.89%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):